flyer’s creek wind farm - best practice, and better practice

12
Flyer’s Creek Wind Farm Best practice, and better practice Ketan Joshi, Research and Communications Officer 16 th of June, 2014

Upload: sydney

Post on 07-Feb-2023

0 views

Category:

Documents


0 download

TRANSCRIPT

Flyer’s Creek Wind FarmBest practice, and better practice

Ketan Joshi, Research and Communications Officer16th of June, 2014

Agenda Arial Bold 28pt

2

• Overview• What we did well• What we can do better

Presenter: Ketan Joshi Research and Communications Officer

+61 2 8031 [email protected]

Agenda

Anger, Emotion, Outrage

3

My first published article explored how a mix of myth and emotion can derail discourse

http://reneweconomy.com.au/2012/anti-wind-turbine-syndrome-we-need-to-clear-the-air-95349

Flyer’s Creek Wind Farm

4http://www.blayneychronicle.com.au/story/1087917/shires-wind-powered-future/

The proposal first began in 2008, and now incorporates community ownership / engagement mechanisms

Initial Consultation

5Via Infigen Senior Develop Manager Jonathan Upson

• Two farmers approached Infigen Energy

• Infigen visited the site, saw more landowners, and met the Blayney Shire Council CEO on our first trip to the site

• Preliminary feasibility studies were promising

• Negotiations proceeded with 15 Landowners with regards to formal 30+ year lease agreements

2008 2009 2010 2011 2012 2013 2014

Project Announced

Community Information Days

EA + Planning lodged

Draft Planning Guidelines Released

Community Information Days

6Development Manager Frank Boland at a Community Consultation meeting for Flyer’s Creek, 2010. Source: Provided

Community Consultation Meetings held to determine feedback from locals on the development

Community Consultation Committee (CCC)

7

Report on the Community Consultation Committee Process Flyers Creek Wind Farm – Blayney NSW available at :www.infigenenergy.com/Media/docs/Report-on-the-Community-Consultation-Committee-Process---Flyers-Creek-6162f673-cc42-4d6c-8302-4b6a804ab89a-0.pdf

“The CCC has provided an opportunity for open discussion and information flow about the proposal and its progress. Because of the involvement of observers in the meeting, this has extended beyond CCC members. This has allowed for an extensive range of views to be put forward”.- Quote from CCC Annual Report, 2013

Central NSW Renewable Energy Cooperative (CENREC)

8http://www.cenrec.com.au/us/cenrec-board/

CENREC’s founding board members, appointed 17 October 2012

CENREC is a community co-operative aimed at raising funds to purchase one of the wind turbines at Flyer’s Creek

Start Community Engagement Early

9http://www.abc.net.au/news/2014-03-21/windfarm-reaction/5335740

A media article about changes to the wind farm approval process (and many other pieces of media coverage) focused on entrenched opponents of the project.

Pre-empt Misinformation

10http://etwasluft.blogspot.com.au/2013/04/anecdotal-evidence.html

Countering misinformation before it’s spread can disarm misinformers

Pre-empt Misinformation

11

National Health and Medical Research Council (2010, 2014)

Association of Australian Acoustical Consultants (2013)

Victorian Department of Health (2013)

NSW Health (2013)

Worksafe Victoria (2013)

Doctors for the Environment Australia (2011)

South Australian Environmental Protection Agency (2013)

Australian Medical Association (2014)

Australian health authorities offer better medical advice than anti-wind activist groups

DisclaimerThis publication is issued by Infigen Energy Limited (“IEL”), Infigen Energy (Bermuda) Limited (“IEBL”) and Infigen Energy Trust (“IET”), with Infigen Energy RE Limited (“IERL”) as responsible entity of IET (collectively “Infigen”). Infigen and its related entities, directors, officers and employees (collectively “Infigen Entities”) do not accept, and expressly disclaim, any liability whatsoever (including for negligence) for any loss howsoever arising from any use of this publication or its contents. This publication is not intended to constitute legal, tax or accounting advice or opinion. No representation or warranty, expressed or implied, is made as to the accuracy, completeness or thoroughness of the content of the information. The recipient should consult with its own legal, tax or accounting advisers as to the accuracy and application of the information contained herein and should conduct its own due diligence and other enquiries in relation to such information.  The information in this presentation has not been independently verified by the Infigen Entities. The Infigen Entities disclaim any responsibility for any errors or omissions in such information, including the financial calculations, projections and forecasts. No representation or warranty is made by or on behalf of the Infigen Entities that any projection, forecast, calculation, forward-looking statement, assumption or estimate contained in this presentation should or will be achieved. None of the Infigen Entities guarantee the performance of Infigen, the repayment of capital or a particular rate of return on Infigen Stapled Securities.  IEL and IEBL are not licensed to provide financial product advice. This publication is for general information only and does not constitute financial product advice, including personal financial product advice, or an offer, invitation or recommendation in respect of securities, by IEL, IEBL or any other Infigen Entities. Please note that, in providing this presentation, the Infigen Entities have not considered the objectives, financial position or needs of the recipient. The recipient should obtain and rely on its own professional advice from its tax, legal, accounting and other professional advisers in respect of the recipient’s objectives, financial position or needs.  This presentation does not carry any right of publication. Neither this presentation nor any of its contents may be reproduced or used for any other purpose without the prior written consent of the Infigen Entities.

IMPORTANT NOTICENothing in this presentation should be construed as either an offer to sell or a solicitation of an offer to buy Infigen securities in the United States or any other jurisdiction.Securities may not be offered or sold in the United States or to, or for the account or benefit of, US persons (as such term is defined in Regulation S under the US Securities Act of 1933) unless they are registered under the Securities Act or exempt from registration.

12